ArticleNature communications2026
4D metallic metamaterials for bone implants via biodegradation.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
4D scaffolds offer transformative potential for bone implants. Yet their application to metallic materials is constrained by the scarcity of suitable alloys and the requirement for harsh external stimuli to trigger shape change. Here, we introduce 4D metallic metamaterials driven by controlled biodegradation that combine biodegradable constraints with biometals of higher corrosion potential. We show that upon electrochemical degradation of the constraint, the metamaterials recover their original geometry-via stretching, bending, or expansion-generating programmable recovery forces tuned through structural design parameters. We demonstrate that when turned into scaffolds for bone implants, the 4D metallic metamaterials are cytocompatible and promote bone regeneration through the synergistic effects of bioactivity and mechanical stimulation in vivo. This strategy establishes a paradigm in 4D shape transformation of metal via metamaterial design, enabling bioactive, self-recovering implants with broad applicability across biomedical engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.